Immune checkpoint inhibition in COVID-19: risks and benefits

PS Pezeshki, N Rezaei - Expert Opinion on Biological Therapy, 2021 - Taylor & Francis
… However, due to complex modifications in the immune cell … of immune checkpoint inhibitors
to treat COVID-19 is an option. Table 1 lists the clinical trials that are using ICI for COVID-19

Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

M Bersanelli - Immunotherapy, 2020 - Taylor & Francis
… undergoing immune checkpoint blockade could be … COVID-19 pathogenesis & immune
checkpoint blockade In the recent weeks, in the countries heavily interested by the COVID-19

Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis

W Qian, Y Ye, L Zuo, T Song, Q Xu, Y Wang… - …, 2021 - Taylor & Francis
… the effects of immune checkpoint inhibitors (ICIs) on the prognosis of COVID-19. Materials &
… Thirteen studies comprising of 4614 cancer patients with COVID-19 were included. Results: …

[HTML][HTML] Immune-checkpoint inhibitors from cancer to COVID19: A promising avenue for the treatment of patients with COVID19

S Vivarelli, L Falzone, F Torino… - International …, 2021 - spandidos-publications.com
… off‑label for the treatment of COVID19, in association with the … relies on the use of
immunecheckpoint inhibitors (ICIs). In … In fact, patients with severe and critical COVID19, even …

[HTML][HTML] COVID-19 and immune checkpoint inhibitors: initial considerations

RJ Sullivan, DB Johnson, BI Rini… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
… The initial published series of COVID-19 in patients with … immune checkpoint inhibitors
(ICIs), on COVID-19 severity. … the role of immune checkpoints in COVID-19 infection. Clinical …

Immune checkpoint inhibitors for cancer therapy in the COVID-19 era

M Maio, O Hamid, J Larkin, A Covre, M Altomonte… - Clinical Cancer …, 2020 - AACR
immune intersection between COVID-19 … , immune checkpoint inhibitors (ICI) seem to require
major attention as they may act at the crossroads between cancer treatment and COVID-19

Impact of immune checkpoint inhibitors on COVID-19 severity in patients with cancer

R Tan, C Yun, A Seetasith, D Sheinson, R Walls… - The …, 2022 - academic.oup.com
… data on the use of immune checkpoint inhibitors (ICIs) before COVID-19 diagnosis and
its association with severity and survival outcomes in cancer patients who contracted COVID-19. …

[HTML][HTML] On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19

T Gambichler, J Reuther, CH Scheel… - … for ImmunoTherapy of …, 2020 - ncbi.nlm.nih.gov
immune responses against tumor cells. Immune checkpoint inhibitors (ICI) boost antitumor
immune responses by interrupting coinhibitory signaling pathways to promote immune-…

Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?

J Kattan, C Kattan, T Assi - Immunotherapy, 2020 - Taylor & Francis
… The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2… Immune checkpoint
inhibitors have largely impacted the … cancer patients during the coronavirus pandemic in order to …

[HTML][HTML] Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

A Rogiers, IP Da Silva, C Tentori… - … for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
… Patients with cancer who are infected with severe acute respiratory syndrome coronavirus
2 (… The impact of immune checkpoint inhibition (ICI) on the severity of COVID-19 illness is …